Evidence map›Paper›PMID 23182561›Full record

ReviewObstetrics and gynecology clinics of North America2012

A new approach to primary ovarian insufficiency.

Saima Rafique, Evelina W Sterling, Lawrence M Nelson

Registry-linked trialAbstract readReview
In one paragraph

Review in Obstetrics and gynecology clinics of North America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05443282 (Serum Prolidase Activity in Primary Ovarian Insufficiency), which is not on this map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05443282 completednot on this mapstarted 2021, after this paper: background citation

Serum Prolidase Activity in Primary Ovarian Insufficiency

TypeobservationalSponsorAnkara City Hospital BilkentRan2021 to 2022Enrolled133ConditionsOxidative Stress, Ovarian Insufficiency, Primary, Ovarian Failure, PrematureArmsProlidase Level, Follicle Stimulating Hormone Level, Estradiol Level, Proline Level, Hydroxyproline Level
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Clinical Utilities of Anti-Müllerian Hormone.Journal of clinical medicine · 2022
    Review
  8. A Docosahexaenoic Acid Derivative (Molecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. The Scenario of Adoption and Foster Care in Relation to the Reproductive Medicine Practice in Asia.International journal of environmental research and public health · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saima RafiqueIntramural Research Program on Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Building 10, CRC, Room 1-3140, Bethesda, MD 20892-1109, USA.
Evelina W Sterling
Lawrence M Nelson

Funding

Preconception Health and Reproductive Natural HistoryZIAHD000633 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI NELSON, LAWRENCE M · 2009 to 2016
$7.1M
Intramural NIH HHS ZIA HD000633
6 · The paper itself

Abstract

There is a need for a new approach to managing women with primary ovarian insufficiency. This condition is a serious chronic disease that may have far reaching effects on physical and emotional health. An integrative and collaborative approach to management works best. To maintain wellness, most women with primary ovarian insufficiency need to reassess their primary source of meaning and purpose in life and how this diagnosis may have threatened that part of who they are. They also need assessment with regard to bone health, thyroid and adrenal function, determination of FMR1 premutation and karyotype status, and ongoing estradiol-progestin hormone replacement.

Indexed as

Estrogen Replacement TherapyAdultCounselingEstradiolFemaleFragile X Messenger Ribonucleoprotein 1HumansMenopause, PrematureMutationPolymorphism, Single NucleotidePregnancyPrimary Ovarian InsufficiencyProgestinsPrognosisEstradiolFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Progestins

Identifiers

PMID23182561
PMCPMC3727655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.